Connecting the dots...Provectus Biopharmaceuticals
Pages
(Move to ...)
Disclosures
The Blog
Current News
Archived News
Investment and Other Letters
Presentations
Blog Readership Statistics
About the Blogger
▼
March 19, 2014
Boehringer Ingelheim Joins Pfizer on Provectus' Strategic Advisory Board
Dr. Joseph M. Chalil, M.D. from Boehringer Ingelheim
joins Pfizer's Dr. Craig Eagle, M.D. and Bob Miglani on Provectus' strategic advisory board. Boehringer is a private company with
nearly $20 billion of sales in 2012
.
Click to enlarge the table.
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment